Structures by: Khan R. A.
Total: 23
C6H2N3O7,C21H15N2,H2O
C6H2N3O7,C21H15N2,H2O
New Journal of Chemistry (2020) 44, 46 20092-20100
a=7.1550(7)Å b=13.5698(12)Å c=13.6958(13)Å
α=115.283(3)° β=100.531(3)° γ=94.796(3)°
C2H6OS,C6H2N3O7,C31H19N2,1[C2H6SO]
C2H6OS,C6H2N3O7,C31H19N2,1[C2H6SO]
New Journal of Chemistry (2020) 44, 46 20092-20100
a=7.4343(5)Å b=30.238(2)Å c=16.0736(11)Å
α=90° β=98.342(2)° γ=90°
C88H100Cl9Cu4N12O24
C88H100Cl9Cu4N12O24
RSC Adv. (2017) 7, 76 47920
a=12.790(5)Å b=14.351(5)Å c=15.034(5)Å
α=109.079(5)° β=91.480(5)° γ=114.551(5)°
C23H17CuN5O6
C23H17CuN5O6
RSC Adv. (2017) 7, 57 36056
a=8.009(5)Å b=8.714(5)Å c=29.961(5)Å
α=90° β=94.39° γ=90°
VO(acac-NMe2)2
C18H26N2O5V
J. Chem. Soc., Dalton Trans. (2001) 22 3337-3345
a=7.005(2)Å b=19.610(6)Å c=14.601(4)Å
α=90.00° β=90.19(2)° γ=90.00°
C6H20Cl2N2O2Sn
C6H20Cl2N2O2Sn
Dalton transactions (Cambridge, England : 2003) (2014) 43, 6 2534-2548
a=17.228(3)Å b=8.8924(13)Å c=12.8756(19)Å
α=90.00° β=129.374(2)° γ=90.00°
C54H56Cu4N8O8,Na,ClO4
C54H56Cu4N8O8,Na,ClO4
Dalton transactions (Cambridge, England : 2003) (2013) 42, 34 12495-12506
a=35.6139(6)Å b=35.6139(6)Å c=11.47320(10)Å
α=90.0000° β=90.0000° γ=120.0000°
C51H76Cu2N4O4,1.5(H2O)
C51H76Cu2N4O4,1.5(H2O)
Dalton transactions (Cambridge, England : 2003) (2013) 42, 34 12495-12506
a=23.2607(12)Å b=19.7554(10)Å c=28.1663(14)Å
α=90.00° β=101.9139(15)° γ=90.00°
Sulfacetamide4-aminopyridineSalt
C8H10N2O3S,C5H6N2
CrystEngComm (2014) 16, 26 5859
a=7.7413(7)Å b=17.8726(16)Å c=11.0065(10)Å
α=90.00° β=97.8790(10)° γ=90.00°
Sulfacetamide4,4'bipyridinecocrystal
C8H10N2O3S,C5H4N1
CrystEngComm (2014) 16, 26 5859
a=11.6469(9)Å b=10.4670(6)Å c=12.4421(9)Å
α=90.00° β=116.510(10)° γ=90.00°
SulfacetamideIsonicotinamidecocrystal
C8H10N2O3S,C6H6N2O,C6H6N2O
CrystEngComm (2014) 16, 26 5859
a=10.7667(4)Å b=9.7508(4)Å c=21.1014(7)Å
α=90.00° β=96.176(3)° γ=90.00°
SulfacetamideCaffeinecocrystal
C8H10N2O3S,C8H10N4O2
CrystEngComm (2014) 16, 26 5859
a=7.1821(6)Å b=30.430(3)Å c=8.8188(7)Å
α=90.00° β=107.6790(10)° γ=90.00°
SulfacetamideTheophyllinecocrystal
C8H10N2O3S,C7H8N4O2
CrystEngComm (2014) 16, 26 5859
a=8.6640(7)Å b=14.9675(13)Å c=15.3632(15)Å
α=110.234(2)° β=106.3650(10)° γ=97.2830(10)°
C12H13Cu0.5O5
C12H13Cu0.5O5
Dalton transactions (Cambridge, England : 2003) (2015) 44, 22 10330-10342
a=8.7505(2)Å b=5.0769(2)Å c=26.2226(8)Å
α=90.00° β=96.304(3)° γ=90.00°
Bis(2-pyridylmethyl)ammonium perchlorate
C12H14N31,Cl1O41
Acta Crystallographica Section E (2002) 58, 8 o858-o859
a=11.3201(18)Å b=14.422(2)Å c=17.073(3)Å
α=90.00° β=90.00° γ=90.00°
Bis(2-pyridylethyl)ammonium perchlorate
C14H18N31,ClO41
Acta Crystallographica Section E (2002) 58, 11 o1204-o1206
a=7.4093(11)Å b=9.0987(11)Å c=12.161(2)Å
α=88.477(13)° β=82.986(17)° γ=80.079(12)°
Bis[2-(2-pyridinio)ethyl]ammonium triperchlorate
C14H20N33,3ClO41
Acta Crystallographica Section E (2002) 58, 11 o1207-o1209
a=8.6789(8)Å b=8.7858(10)Å c=15.1139(15)Å
α=105.984(8)° β=94.188(8)° γ=99.581(9)°
1-[2-(4-Chlorophenyl)acetyl]-4-(2-methoxyphenyl)thiosemicarbazide
C16H16ClN3O2S
Acta Crystallographica Section E (2007) 63, 7 o3299-o3299
a=5.935(5)Å b=16.970(5)Å c=17.038(5)Å
α=90.000° β=98.948(5)° γ=90.000°
3-(4-Fluorobenzyl)-4-(2-methoxyphenyl)-1H-1,2,4-triazole-5(4H)-thione
C16H14FN3OS
Acta Crystallographica Section E (2007) 63, 8 o3501-o3501
a=7.4910(7)Å b=16.1656(15)Å c=12.9147(12)Å
α=90.00° β=91.956(2)° γ=90.00°
4-Methyl-3-nitropyridin-2-amine
C6H7N3O2
Acta Crystallographica Section E (2009) 65, 7 o1615
a=7.3776(6)Å b=12.8673(11)Å c=7.3884(6)Å
α=90° β=104.364(4)° γ=90°
2,2-Bis(hydroxymethyl)-2,3-dihydro-1<i>H</i>-pyrrolizin-1-one
C9H11NO3
Acta Crystallographica Section E (2010) 66, 7 o1579-o1580
a=10.2601(8)Å b=39.863(3)Å c=12.4120(10)Å
α=90.00° β=90.273(6)° γ=90.00°
C19H32Cl4N2RuSn
C19H32Cl4N2RuSn
Organometallics (2013) 32, 9 2546
a=11.1083(14)Å b=13.7513(17)Å c=16.122(2)Å
α=90.00° β=93.539(2)° γ=90.00°
C21H23ClO4Ru
C21H23ClO4Ru
New Journal of Chemistry (2021)
a=12.1970(5)Å b=8.0942(3)Å c=19.7477(8)Å
α=90° β=90° γ=90°